Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-13 Sale | 2026-03-13 8:16 pm | Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer | 1,410 | $55.23 | $77,867 | 18,319 (Direct) | View |
| 2026-03-13 Sale | 2026-03-13 8:16 pm | Xenon Pharmaceuticals Inc. | XENE | DiFabio Andrea Chief Legal Officer | 1,342 | $55.22 | $74,112 | 18,551 (Direct) | View |
| 2026-03-13 Sale | 2026-03-13 8:16 pm | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 7,308 | $55.23 | $403,584 | 71,723 (Indirect Direct) | View |
| 2026-03-10 Sale | 2026-03-11 7:21 pm | Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer | 2,771 | $60.11 | $166,559 | 12,229 (Direct) | View |
| 2026-03-10 Sale | 2026-03-11 7:20 pm | Xenon Pharmaceuticals Inc. | XENE | DiFabio Andrea Chief Legal Officer | 2,607 | $60.11 | $156,702 | 12,393 (Direct) | View |
| 2026-03-09 Sale | 2026-03-11 7:20 pm | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 281,269 | $60.32 | $16,966,500 | 49,031 (Indirect Direct) | View |
| 2026-01-02 Sale | 2026-01-02 6:49 pm | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 40,000 | $44.43 | $1,777,093 | 20,300 (Indirect Direct) | View |
| 2025-12-05 Sale | 2025-12-09 7:40 pm | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 25,205 | $45.33 | $1,142,513 | 20,300 (Indirect Direct) | View |
| 2025-11-28 Sale | 2025-12-03 8:20 pm | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 97 | $45.01 | $4,366 | 45,505 (Indirect Direct) | View |
| 2025-10-01 Sale | 2025-10-01 7:17 pm | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT, CEO & INTERIM CFO | 25,000 | $40.16 | $1,004,000 | 45,602 (Indirect Direct) | View |
| 2025-06-05 Sale | 2025-06-06 5:58 pm | Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director | 3 | $30.48 | $91 | 26,798 (Direct) | View |
| 2025-01-23 Sale | 2025-01-27 8:28 pm | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 55,000 | $40.25 | $2,213,997 | 100,700 (Indirect Direct) | View |
| 2024-12-18 Sale | 2024-12-19 6:57 pm | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 18,709 | $41.21 | $770,912 | 6,000 (Direct) | View |
| 2024-11-22 Sale | 2024-11-22 7:48 pm | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 4,891 | $41.08 | $200,947 | 28,475 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-12 Exercise | 2026-03-13 8:16 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer | 3,750 | $0 | 18,319 (Direct) | View |
| 2026-03-12 Exercise | 2026-03-13 8:16 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | DiFabio Andrea Chief Legal Officer | 3,750 | $0 | 18,551 (Direct) | View |
| 2026-03-12 Exercise | 2026-03-13 8:16 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 12,500 | $0 | 71,723 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 7:21 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer | 7,500 | $0 | 12,229 (Direct) | View |
| 2026-03-09 Exercise | 2026-03-11 7:21 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer | 7,500 | $0 | 12,229 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 7:20 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | DiFabio Andrea Chief Legal Officer | 7,500 | $0 | 12,393 (Direct) | View |
| 2026-03-09 Exercise | 2026-03-11 7:20 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | DiFabio Andrea Chief Legal Officer | 7,500 | $0 | 12,393 (Direct) | View |
| 2026-03-09 Exercise | 2026-03-11 7:20 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 75,000 | $8.4 | 49,031 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 7:20 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 20,000 | $0 | 49,031 (Direct) | View |
| 2026-03-09 Exercise | 2026-03-11 7:20 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 105,000 | $4.75 | 49,031 (Direct) | View |
| 2026-03-09 Exercise | 2026-03-11 7:20 pm | N/A 2027-03-12 | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 290,000 | $0 | 49,031 (Direct) | View |
| 2026-03-09 Exercise | 2026-03-11 7:20 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 25,000 | $3.1 | 49,031 (Direct) | View |
| 2026-03-09 Exercise | 2026-03-11 7:20 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 65,000 | $9.44 | 49,031 (Direct) | View |
| 2026-01-09 Option Award | 2026-01-09 6:54 pm | N/A 2036-01-08 | Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2026-01-09 Option Award | 2026-01-09 6:53 pm | N/A 2036-01-08 | Xenon Pharmaceuticals Inc. | XENE | Cline Darren S Chief Commercial Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2026-01-09 Option Award | 2026-01-09 6:52 pm | N/A 2036-01-08 | Xenon Pharmaceuticals Inc. | XENE | DiFabio Andrea Chief Legal Officer | 95,000 | $0 | 95,000 (Direct) | View |
| 2026-01-09 Option Award | 2026-01-09 6:51 pm | N/A 2036-01-08 | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 415,000 | $0 | 415,000 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-02 6:49 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 40,000 | $7.49 | 20,300 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-02 6:49 pm | N/A 2026-03-10 | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 40,000 | $0 | 20,300 (Direct) | View |
| 2025-10-15 Option Award | 2025-10-17 6:43 pm | N/A 2035-10-14 | Xenon Pharmaceuticals Inc. | XENE | Kelly Thomas Patrick Chief Financial Officer | 255,000 | $0 | 255,000 (Direct) | View |
Ownership | 2025-10-17 6:41 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | Kelly Thomas Patrick Chief Financial Officer | 0 | $0 | 0 (Direct) | View |
| 2025-10-01 Exercise | 2025-10-01 7:17 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT, CEO & INTERIM CFO | 25,000 | $7.69 | 45,602 (Direct) | View |
| 2025-10-01 Exercise | 2025-10-01 7:17 pm | N/A 2025-12-17 | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT, CEO & INTERIM CFO | 25,000 | $0 | 45,602 (Direct) | View |
| 2025-06-23 Option Award | 2025-06-24 9:35 pm | N/A 2035-06-22 | Xenon Pharmaceuticals Inc. | XENE | Cline Darren S Chief Commercial Officer | 185,800 | $0 | 185,800 (Direct) | View |
Ownership | 2025-06-24 9:33 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | Cline Darren S Chief Commercial Officer | 0 | $0 | 0 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 6:00 pm | N/A 2035-06-04 | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 19,657 | $0 | 19,657 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 6:00 pm | N/A 2035-06-04 | Xenon Pharmaceuticals Inc. | XENE | Machado Patrick Director | 19,657 | $0 | 19,657 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:59 pm | N/A 2035-06-04 | Xenon Pharmaceuticals Inc. | XENE | Gover Justin D. Director | 19,657 | $0 | 19,657 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:59 pm | N/A 2035-06-04 | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 19,657 | $0 | 19,657 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:58 pm | N/A 2035-06-04 | Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director | 19,657 | $0 | 26,798 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:57 pm | N/A 2035-06-04 | Xenon Pharmaceuticals Inc. | XENE | Cannon Gillian Director | 19,657 | $0 | 19,657 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:57 pm | N/A 2035-06-04 | Xenon Pharmaceuticals Inc. | XENE | Svoronos Dawn Director | 19,657 | $0 | 19,657 (Direct) | View |
| 2025-05-14 Exercise | 2025-05-16 5:59 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director | 5,144 | $12.57 | 7,144 (Direct) | View |
| 2025-05-14 Exercise | 2025-05-16 5:59 pm | N/A 2025-05-20 | Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director | 5,144 | $0 | 7,144 (Direct) | View |
| 2025-03-12 Option Award | 2025-03-13 7:33 pm | N/A 2035-03-11 | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 325,000 | $0 | 325,000 (Direct) | View |
| 2025-03-12 Option Award | 2025-03-13 7:31 pm | N/A 2035-03-11 | Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer | 95,000 | $0 | 95,000 (Direct) | View |
| 2025-03-12 Option Award | 2025-03-13 7:30 pm | N/A 2035-03-11 | Xenon Pharmaceuticals Inc. | XENE | DiFabio Andrea Chief Legal Officer | 95,000 | $0 | 95,000 (Direct) | View |
| 2025-01-23 Exercise | 2025-01-27 8:28 pm | N/A 2025-03-16 | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 55,000 | $0 | 100,700 (Direct) | View |
| 2025-01-23 Exercise | 2025-01-27 8:28 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 55,000 | $17.76 | 100,700 (Direct) | View |
| 2024-12-18 Tax Withholding | 2024-12-19 6:57 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 6,625 | $41.28 | 6,000 (Direct) | View |
| 2024-12-18 Exercise | 2024-12-19 6:57 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 16,000 | $11.58 | 6,000 (Direct) | View |
| 2024-12-18 Exercise | 2024-12-19 6:57 pm | N/A 2029-09-15 | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 25,334 | $0 | 6,000 (Direct) | View |
| 2024-12-18 Exercise | 2024-12-19 6:57 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 9,334 | $9.44 | 6,000 (Direct) | View |
| 2024-11-22 Tax Withholding | 2024-11-22 7:48 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 1,695 | $39.8 | 28,475 (Direct) | View |
| 2024-11-22 Exercise | 2024-11-22 7:48 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 3,086 | $13.48 | 28,475 (Direct) | View |
| 2024-11-22 Exercise | 2024-11-22 7:48 pm | N/A 2026-06-01 | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 6,586 | $0 | 28,475 (Direct) | View |
| 2024-11-22 Exercise | 2024-11-22 7:48 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 3,500 | $7.38 | 28,475 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-05 5:43 pm | N/A 2034-06-04 | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 15,542 | $0 | 15,542 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-05 5:42 pm | N/A 2034-06-04 | Xenon Pharmaceuticals Inc. | XENE | Machado Patrick Director | 15,542 | $0 | 15,542 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-05 5:42 pm | N/A 2034-06-04 | Xenon Pharmaceuticals Inc. | XENE | Gover Justin D. Director | 15,542 | $0 | 15,542 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-05 5:42 pm | N/A 2034-06-04 | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 15,542 | $0 | 15,542 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-05 5:42 pm | N/A 2034-06-04 | Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director | 15,542 | $0 | 15,542 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-05 5:41 pm | N/A 2034-06-04 | Xenon Pharmaceuticals Inc. | XENE | Cannon Gillian Director | 15,542 | $0 | 15,542 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-05 5:41 pm | N/A 2034-06-04 | Xenon Pharmaceuticals Inc. | XENE | Svoronos Dawn Director | 15,542 | $0 | 15,542 (Direct) | View |
| 2024-03-11 Option Award | 2024-03-12 6:42 pm | N/A 2034-03-10 | Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer | 100,000 | $0 | 100,000 (Direct) | View |